Journal of Clinical Investigation -- Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

Article tools

Author information

Find articles by
Stewart, P. M. in:
JCI | PubMed | Google Scholar
Find articles by
Edwards, C. R. in:
JCI | PubMed | GoogleScholar

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

P M Stewart, J E Corrie, C H Shackleton and C R Edwards

Department of Medicine, Western General Hospital, Edinburgh, Scotland.

Published July, 1988

The first adult case of 11 beta-hydroxysteroid dehydrogenase (11 beta-OHSD) deficiency is described. The impaired conversion of cortisol to cortisone (indicated by urinary cortisol and cortisone metabolites and failure to metabolize 11 alpha-[3H]cortisol to [3H]H2O), was associated with hypertension, hypokalemia, and suppression of the renin-angiotensin-aldosterone system. When established on a fixed Na+/K+ intake, dexamethasone, given orally, produced a natriuresis and potassium retention. Plasma renin activity became detectable. When hydrocortisone (10 mg daily s.c. for 4 d) was added, there was marked Na+ retention, a kaliuresis (urinary Na+/K+ falling from 1.2 to 0.15), with suppression of plasma renin activity and an increase in blood pressure. These changes were also seen with the subject on no treatment. Conversion of cortisone to cortisol was not affected. These results suggest that cortisol acts as a potent mineralocorticoid in 11 beta-OHSD deficiency. The major site for the oxidation of cortisol to cortisone is the kidney. In this patient congenital deficiency of 11 beta-OHSD results in high intrarenal cortisol levels which then act on renal type I mineralocorticoid receptors. This condition can be treated with dexamethasone, which suppresses cortisol secretion and binds to the type II glucocorticoid receptor. We suggest that 11 beta-OHSD exerts a critical paracrine role in determining the specificity of the type I receptor. In the normal state cortisol is converted by 11 beta-OHSD to cortisone which thus allows aldosterone to bind preferentially to the type I receptors in the kidney and gut. In this patient deficiency of 11 beta-OHSD results in high intrarenal cortisol concentrations that then bind to the type I receptor.

Articles that cite
this article:

Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
Yuri Kotelevtsev, Roger W. Brown, Stewart Fleming, Christopher Kenyon, Christopher R.W. Edwards, Jonathan R. Seckl, John J. Mullins
J Clin Invest 103(5):683. [CrossRef]

Yuri Kotelevtsev, Jonathan Seckl, John Mullins
CURR OPIN ENDOCRINOL DIABETES 6(3):191. [CrossRef]

THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MAN
J. A. Whitworth, P. M. Stewart, D. Burt, S. M. Atherden, C. R. W. Edwards
Clin Endocrinol (Oxf) 31(3):355. [CrossRef]

HORMONES AND HYPERTENSION
ROBERT Fraser, DAVID L. Davies, JOHN M. C. Connell
Clin Endocrinol (Oxf) 31(6):701. [CrossRef]

Airong Li, Kevin Li, Suemi Marui, Zygmunt Krozowski, Marcelo Batista, Christopher Whorwood, Ive Arnhold, Cedric Shackleton, Berenice Mendonca, Paul Stewart
J Hypertens 15(12):1397. [CrossRef]

Steroids as Regulators of the Mammalian Immune Response.
Raymond A. Daynes, Barbara A. Araneo, Jon Hennebold, Elena Enioutina, Hong Hua mu
J Invest Dermatol 105(s1):14S. [CrossRef]

Glucocorticoids and the kidney. Review Article
George J Mangos, Judith A Whitworth, Paula M Williamson, John J Kelly
Nephrology (Carlton) 8(6):267. [CrossRef]

Stan Van uum, Alphons Houben, Ad Hermus, Abraham Kroon, Brian Walker, C Sweep, Paul Smits, Peter De leeuw, Jacques Lenders
J Hypertens 20(11):2275. [CrossRef]

Roberto Franco-saenz, Peijuan Shen, Soon Lee, George Cicila, W Henrich
J Hypertens 17(8):1089. [CrossRef]

When is cortisol a mineralocorticoid?
John Clore, Anton Schoolwerth, Charles O Watlington
Kidney Int 42(6):1297. [CrossRef]

CORTISOL AND HYPERTENSION
JJ Kelly, G. Mangos, PM Williamson, JA Whitworth
Clin Exp Pharmacol Physiol 25(s1):S51. [CrossRef]

Research Article

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

Browse pages

Articles that cite
this article:

Research Article

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

Browse pages

Articles that cite this article:

Articles that cite
this article: